DK154887A - Farmaceutisk praeparat indenholdende indomethacin - Google Patents

Farmaceutisk praeparat indenholdende indomethacin

Info

Publication number
DK154887A
DK154887A DK154887A DK154887A DK154887A DK 154887 A DK154887 A DK 154887A DK 154887 A DK154887 A DK 154887A DK 154887 A DK154887 A DK 154887A DK 154887 A DK154887 A DK 154887A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
preparation containing
containing indomethacin
indomethacin
carboxylic acid
Prior art date
Application number
DK154887A
Other languages
English (en)
Other versions
DK154887D0 (da
Inventor
Kim Drummond Rainsford
Michael Wellesley Whitehouse
Original Assignee
Kim Drummond Rainsford
Whitehouse Michael W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Drummond Rainsford, Whitehouse Michael W filed Critical Kim Drummond Rainsford
Publication of DK154887D0 publication Critical patent/DK154887D0/da
Publication of DK154887A publication Critical patent/DK154887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK154887A 1986-03-27 1987-03-26 Farmaceutisk praeparat indenholdende indomethacin DK154887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868607662A GB8607662D0 (en) 1986-03-27 1986-03-27 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
DK154887D0 DK154887D0 (da) 1987-03-26
DK154887A true DK154887A (da) 1987-09-28

Family

ID=10595349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK154887A DK154887A (da) 1986-03-27 1987-03-26 Farmaceutisk praeparat indenholdende indomethacin

Country Status (17)

Country Link
US (1) US4885279A (da)
EP (1) EP0239332B1 (da)
JP (1) JPS6322017A (da)
AT (1) ATE60993T1 (da)
AU (1) AU593084B2 (da)
CA (1) CA1285488C (da)
DE (1) DE3768110D1 (da)
DK (1) DK154887A (da)
ES (1) ES2038658T3 (da)
GB (1) GB8607662D0 (da)
GR (1) GR3001520T3 (da)
IE (1) IE59636B1 (da)
NO (1) NO871187L (da)
NZ (1) NZ219717A (da)
PH (1) PH25296A (da)
PT (1) PT84580B (da)
ZA (1) ZA872137B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321655D0 (en) * 1993-10-20 1993-12-08 Glyzinc Pharma Ltd Pharmaceutical formulation of aspirin and salicylates
US5518738A (en) * 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
DE10352511A1 (de) * 2003-11-07 2005-06-16 Ernst-Moritz-Arndt-Universität Greifswald Verwendung von MRP4-Inhibitoren zur Behandlung und/oder Prophylaxe kardiovaskulärer Erkrankungen
HU231309B1 (hu) 2014-02-25 2022-11-28 Darholding Kft. Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
AU511852B2 (en) * 1977-11-09 1980-09-11 Australian National University, The Formulating aspirin andthe like
DE2966867D1 (en) * 1979-01-12 1984-05-10 Univ Australian Protection of the gastric mucosal lining from damage by aspirin and related drugs
US4228161A (en) * 1979-03-28 1980-10-14 Merck & Co., Inc. Anti-inflammatory combination having reduced ulcerogenicity
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
GB2155329A (en) * 1984-03-08 1985-09-25 Kim Drummond Rainsford A pharmaceutical formulation containing azapropazone
KR930000029B1 (ko) * 1984-03-14 1993-01-06 제롬 꼬르비에르 N-아실 인돌류 활성성분의 용해방법
DE3587151T2 (de) * 1984-12-20 1993-07-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

Also Published As

Publication number Publication date
EP0239332B1 (en) 1991-02-27
DE3768110D1 (de) 1991-04-04
ZA872137B (en) 1987-10-28
JPH0572887B2 (da) 1993-10-13
AU593084B2 (en) 1990-02-01
EP0239332A2 (en) 1987-09-30
PT84580A (en) 1987-04-01
US4885279A (en) 1989-12-05
DK154887D0 (da) 1987-03-26
AU7071387A (en) 1987-10-01
ES2038658T3 (es) 1993-08-01
GB8607662D0 (en) 1986-04-30
JPS6322017A (ja) 1988-01-29
ATE60993T1 (de) 1991-03-15
CA1285488C (en) 1991-07-02
IE59636B1 (en) 1994-03-09
NO871187D0 (no) 1987-03-23
IE870742L (en) 1987-09-27
GR3001520T3 (en) 1992-11-23
NO871187L (no) 1987-09-28
EP0239332A3 (en) 1988-03-02
NZ219717A (en) 1989-06-28
PH25296A (en) 1991-04-30
PT84580B (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
NO307772B1 (no) Fysiologisk aktive, polypeptid-holdige, farmasøytiske preparater
MY102459A (en) Oral sustained release pharmaceutical preparation.
AU528190B2 (en) Device for oral administration of drugs to ruminant animals
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
ES2048594T3 (es) Formulaciones farmaceuticas.
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
PT83094A (pt) Dispositivos proprios para a administracao de medicamentos a pacientes
ATE71293T1 (de) Arzneiformulierung.
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ES2097162T3 (es) Utilizacion de acidos grasos de cadena corta en alimentacion clinica.
DK154887A (da) Farmaceutisk praeparat indenholdende indomethacin
DE3766334D1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
DK576687A (da) Terapeutisk aktive alkensyrederivater
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
DK160388D0 (da) Tert-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 og syreadditionssalte deraf til anvendelse som terapeutisk aktivt stof
SE8800888L (sv) Foerfarande foer framstaellning av ett laekemedelspreparat foer foerebyggande och behandling av alkoholism
TH2728EX (th) หน้ากากสำหรับยึดท่อยางเพื่อหยุดโลหิตในหลอดอาหารและให้อาหารผู้ป่วย
NO162239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment